N01266 118 — Chicago, Illinois

N01266 118 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

N01266 118 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Pharma SA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for N01266 118?

N01266 118 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has N01266 118 conducted?

N01266 118 has 1 clinical trials on record. Their work covers Epilepsy.

Is N01266 118 accredited by Crixeo Health?

N01266 118 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about N01266 118?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.